Andrew Zolopa
Clinical Trials
- ACTG 5128 Consent for Use of Stored Patient Specimens for Future Testing Recruiting
- ACTG 5001: Long-Term Data Collection From Participants in Adult AIDS Clinical Trials Recruiting
- A5262: A Pilot Efficacy and Safety Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects Recruiting
- ACTG 5240: Phase 2 study of HPV vaccine in HIV-1 Infected Females Recruiting
- ACTG 5241: The Optimized Treatment that includes or Omits NRTIs (OPTIONS) Trial Recruiting
- ACTG 5247: Phase 2 trial to evaluatre the safety, tolerability, and Immunogenicity of ZOSTAVAX in HIV-1 infected Adults Recruiting
- ACTG 5256: A Pilot of Maraviroc for treatment of subjects with suboptimal CD4 counts despite virologic suppression Recruiting
- ACTG 5257: A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers Recruiting
- Pzifer Poem Study: AN INTERNATIONAL, MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY OF THE SAFETY OF MARAVIROC USED WITH OPTIMIZED BACKGROUND THERAPY IN TREATMENT-EXPERIENCED HIV-1 INFECTED PATIENTS Recruiting
- Safety and Efficacy of T Cell Genetic Immunotherapy for HIV No longer recruiting
- Raltegravir substitution for enfuvirtide in patients suffering from injection site reactions (ISRs): The Raleve pilot study No longer recruiting
Help